Blueberries Medical Corp.
BBRRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $4 | $4 | $10 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $6 | $3 | $4 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 63.5% | 22.4% | 69.7% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 34.9% | 29.2% | -7.5% | -176.9% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -221.3% | -423.8% | -572.9% | -781.9% |
| Net Income | -$1 | -$2 | -$1 | -$5 |
| % Margin | -243.6% | -567.3% | -623.4% | -3,709.6% |
| EPS Diluted | -0.003 | -0.008 | -0.009 | -0.035 |
| % Growth | 61.3% | 13.8% | 74.9% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$2 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$2 |